At least one prior systemic therapy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15568 | Adagrasib | A KRAS inhibitor indicated for the treatment of locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy. |
| DB15149 | Futibatinib | A kinase inhibitor used to treat intrahepatic cholangiocarcinoma in previously treated adults. |
| DB06176 | Romidepsin | A histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma. |
| Drug | Drug Name | Phase | Status | Count |
|---|